Assessing the Impact of Rare Polymorphism at CRP on CRP Levels & Atherosclerosis

评估 CRP 罕见多态性对 CRP 水平的影响

基本信息

项目摘要

DESCRIPTION (provided by applicant): Plasma C-Reactive Protein (CRP) level is a biomarker that predicts future risk of cardiovascular disease (CVD). We recently demonstrated that alleles at several common single nucleotide polymorphisms (SNPs) in the CRP gene correlate with plasma CRP levels, and functionally alter the regulation of the CRP promoter. However, the majority of the inter-individual variance in CRP levels remains unexplained. Common SNPs tend to be older than rare SNPs, and therefore have been exposed to longer term natural selection. Thus, it is not unlikely that rare SNPs exist with larger effects on plasma CRP than the known, common SNPs, and these rare SNPs might explain a significant fraction of the remaining variance in plasma CRP. The goal of this application is to discover rare SNPs in the CRP gene, which are of functional relevance in relation to plasma CRP levels and atherosclerotic pathogenesis. Aim 1: We will identify rare SNPs likely to alter CRP levels by resequencing two panels: A. the high (N=376) and low (N=376) tails of the CRP distribution (and age/gender matched controls) in the CARDIA cohort, a cohort of more than 4000 individuals, ages 38 to 50, and B. Severely stenosed cases (N=500) and controls (N=500) from a study of carotid atherosclerotic disease. Aim 2: We will functionally characterize putatively functional SNPs identified in Aim 1, using site-directed mutagenesis of a plasmid containing a CRP-GFP fusion gene to generate allelic constructs, and transient transfection analysis of expression from the allelic constructs to assess functional impacts on protein and RNA levels.
描述(由申请人提供):血浆c反应蛋白(CRP)水平是预测未来心血管疾病(CVD)风险的生物标志物。我们最近证明了CRP基因中几个常见的单核苷酸多态性(snp)的等位基因与血浆CRP水平相关,并在功能上改变了CRP启动子的调节。然而,CRP水平的大部分个体间差异仍未得到解释。常见的snp往往比罕见的snp更古老,因此暴露在更长期的自然选择中。因此,与已知的常见snp相比,罕见snp对血浆CRP的影响更大,这并非不可能,这些罕见snp可能解释了血浆CRP剩余差异的重要部分。本应用程序的目的是发现CRP基因中罕见的snp,这些snp与血浆CRP水平和动脉粥样硬化发病机制具有功能相关性。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Efficient identification of rare variants in large populations: deep re-sequencing the CRP locus in the CARDIA study.
  • DOI:
    10.1093/nar/gkt092
  • 发表时间:
    2013-04
  • 期刊:
  • 影响因子:
    14.9
  • 作者:
    Chen CT;McDavid AN;Kahsai OJ;Zebari AS;Carlson CS
  • 通讯作者:
    Carlson CS
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher S Carlson其他文献

Agnosticism and equity in genome-wide association studies
全基因组关联研究中的不可知论与公平性
  • DOI:
    10.1038/ng0606-605
  • 发表时间:
    2006-06-01
  • 期刊:
  • 影响因子:
    29.000
  • 作者:
    Christopher S Carlson
  • 通讯作者:
    Christopher S Carlson

Christopher S Carlson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher S Carlson', 18)}}的其他基金

Monitoring disease progression in follicular lymphoma with next-gen sequencing
通过下一代测序监测滤泡性淋巴瘤的疾病进展
  • 批准号:
    8799864
  • 财政年份:
    2015
  • 资助金额:
    $ 44万
  • 项目类别:
Monitoring disease progression in follicular lymphoma with next-gen sequencing
通过下一代测序监测滤泡性淋巴瘤的疾病进展
  • 批准号:
    10602854
  • 财政年份:
    2015
  • 资助金额:
    $ 44万
  • 项目类别:
Impact of primary tumor development stage on prognosis and outcome in B-ALL
原发肿瘤发展阶段对 B-ALL 预后和结果的影响
  • 批准号:
    8754687
  • 财政年份:
    2014
  • 资助金额:
    $ 44万
  • 项目类别:
GENETICS
遗传学
  • 批准号:
    7881275
  • 财政年份:
    2010
  • 资助金额:
    $ 44万
  • 项目类别:
WHI Sequencing Project (WHISP)
WHI 测序项目 (WHISP)
  • 批准号:
    7941971
  • 财政年份:
    2009
  • 资助金额:
    $ 44万
  • 项目类别:
WHI Sequencing Project (WHISP)
WHI 测序项目 (WHISP)
  • 批准号:
    7856422
  • 财政年份:
    2009
  • 资助金额:
    $ 44万
  • 项目类别:
Assessing the Impact of Rare Polymorphism at CRP on CRP Levels & Atherosclerosis
评估 CRP 罕见多态性对 CRP 水平的影响
  • 批准号:
    7839796
  • 财政年份:
    2009
  • 资助金额:
    $ 44万
  • 项目类别:
Assessing the Impact of Rare Polymorphism at CRP on CRP Levels & Atherosclerosis
评估 CRP 罕见多态性对 CRP 水平的影响
  • 批准号:
    7367269
  • 财政年份:
    2008
  • 资助金额:
    $ 44万
  • 项目类别:
Assessing the Impact of Rare Polymorphism at CRP on CRP Levels & Atherosclerosis
评估 CRP 罕见多态性对 CRP 水平的影响
  • 批准号:
    7579035
  • 财政年份:
    2008
  • 资助金额:
    $ 44万
  • 项目类别:
Evolutionary analysis of CTCF and potential links to breast cancer phenotypes
CTCF 的进化分析及其与乳腺癌表型的潜在联系
  • 批准号:
    7151882
  • 财政年份:
    2006
  • 资助金额:
    $ 44万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 44万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 44万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 44万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 44万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了